OBRR Lab
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- Points of contact
-
- CBER Acquisition Liaison cbaeracquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a new requirement for a prophylactic vaccine for visceral leishmaniasis. The solicitation is expected to be released on May 1, 2026, with an estimated award date of September 1, 2026. This procurement falls under the Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers category (NAICS 423450).
The estimated award value for this contract ranges from $25,000 to $250,000. Interested parties should direct inquiries to the Food and Drug Administration's Contracting Activity at cbaeracquisitions@fda.hhs.gov. This forecast was posted on January 31, 2026, and no set-aside provisions are being applied to this procurement opportunity.
Forecast text
Prophylactic vaccine for visceral leishmaniasis
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast